SERPINB3 and hepatocellular carcinoma: Data in the present study, showing that SerpinB3-dependent increased HIF-2α stabilization through direct NEDDylation, should then encourage to consider both HIF-2α and NAE1 as putative novel targets for a selective therapeutic strategy designed to interfere with HCC progression.